Abstract: The invention relates to agents with UV radiation-absorbing and/or reflecting action comprising solid, polymorphic, crystal-line or partially crystalline lipid and/or polymer particles, for application to the skin, mucous membranes, scalp, and hair for protection against health-damaging UV radiation and for strengthening the natural skin barrier.

Abstract: An antiperspirant and/or deodorant stick composition is disclosed comprising (a) 10-60 weight % of a volatile silicone such as cyclomethicone; (b) 2-30 weight % of a low melting point wax gelling agent (particularly stearyl alcohol); (c) 1-10 weight % of a high melting point wax (such as hydrogenated castor oil); (d) 0-15 weight % of an emollient which is different from (b) and (c); (e) 0.1-10 weight % of a superabsorbent powder with little or no tack upon wetting such as starch graft homopolymers and copolymers of poly(2-propenamide-co-2-propenioic acid) sodium salt; (f) 0-30 weight % of an antiperspirant active; (g) 0-1 weight % of a dimethicone copolyol; (h) 0.01-0.5 weight % of a selected cooling agent; and (i) 0-5 weight % (particularly 0.1-5 weight %) of a fragrance; wherein the ratio of cooling agent to superabsorbent polymer is in the range of 1:50-1:2.

Abstract: By using 2,4-bis[[4-(2-ethylhexyloxy)-2-hydroxy]phenyl]-6-(4-methoxyphenyl)-1,3,5-triazine, the photostability of dibenzoylmethane derivatives is substantially improved and, indirectly, stabilisation of cinnamic acid esters is also effected, by which means there are made possible photostable cosmetic compositions for protection against UV radiation which have a high sun protection factor and a high absorbance in both the UVA and UVB range.

Abstract: The invention is a user friendly, multi-purpose ointment whose simple basic formula is a combination of karaya gum powder and a vehicle for dispersing, such as petrolatum. It can be designed to treat a variety of skin problems by adding some non-essential ingredients such as Vitamin A&D Ointment, Vitamin E cream or Lotion at the discretion of the user, in addition to various pharmaceuticals based on the cause of the problem such as an antibacterial, an antifungal, an anti-inflammatory agent, an antiviral, an anti-parasitic, or an enzymatic agent at the discretion of the health care provider or user.

Abstract: A stable, high efficacy, low residue surfactant-free, soft solid cosmetic composition (especially an antiperspirant and/or deodorant) comprising: (a) 40-75 weight % of a volatile silicone; (b) 0.5-20 weight % of a non-emulsifying silicone elastomer; (c) 0.1-10 weight % of a of a superabsorbent powder with little or no tack upon wetting; (d) 0.01-0.

Abstract: The current invention is directed to methods of treating or preventing emphysema, pharmaceutical compositions suitable for the treatment or prevention of emphysema and methods for delivering formulations into the lung of a mammal suffering from emphysema. More generally, the invention encompasses the use of 13-cis-retinoic acid to treat or prevent certain chronic obstructive airway disorders, particularly chronic obstructive pulmonary disease including chronic bronchitis, emphysema and asthma in mammals, especially humans that smoke or smoked cigarettes. In another aspect, the present invention encompasses the use of pharmaceutical compositions of 13-cis-retinoic acid to treat emphysema. Moreover, the current invention encompasses the use of electrohydrodynamic aerosol devices, aerosol devices and nebulizers to deliver formulations of 13-cis-retinoic acid into the lung of a mammal suffering from emphysema. The invention also encompasses the systemic use as well as the local use of 13-cis-retinoic acid.

Abstract: The invention relates to cosmetic compositions for topical application for counteracting UV radiation induced skin damage comprising as active substances a first component which comprises inactivated bacteria selected from the group consisting of the genus Bifidobacterium, Actinomycetaceae, Propionimycetaceae, Lactobacillaceae and Coryneform bacteria and a second component which comprises an extract of plant extracellular matrix. Preferably, the plant extracellular matrix is selected from the group consisting of glycoproteins, carbohydrate polymers and arabinogalactan proteins. Processes for using the cosmetic compositions are also described.

Abstract: Stable, clear, antiperspirant microemulsions containing cosmetic oils, antiperspirant salts, and water and combinations of cationic quaternary ammonium salt are provided. These microemulsions can be used in different types of applicators such as roll-on, sponge, mousse, pad, brush, gel and aerosol or non-aerosol spray applicators.

Abstract: The invention relates to sunscreen compositions for humans including naturally occurring sunscreen agents from plants, algae, cyanobacteria, fungi and bacteria that protect against exposure to solar radiation. The active sunscreen agents are compounds that naturally occur in plants, algae, cyanobacteria, fungi and bacteria and derivatives of these compounds.

Abstract: A cosmetic composition for treating nails is provided to remove nail polish, to nourish and strengthen the nails and to moisturize and soften the cuticles around the nails.

Abstract: A method for protecting against UV radiation includes the steps of extracting a cyanin from a plant and applying it to the skin to act as a sunshield. In the preferred embodiments, the plant cyanin is selected from anthocyanin and betacyanin. Optionally, the plant cyanin is derived from a tropical plant, illustratively including the palm family, tropical fruit and nut bearing plants and flowering plants. A sunscreen composition is provided including a plant derived cyanin and a skin-compatible carrier. Optionally, the cyanin is selected from an anthocyanin and a betacyanin, which is present at a concentration ranging from 0.05% to 75% of the weight of the total composition. A sunscreen composition includes the skin-compatible carrier at a concentration ranging from 25% to 99.95% of the weight of the total composition.

Abstract: The present invention is a process of preparing an advanced cosmetic product by combining a high internal phase ratio (HIPR) emollient-in-water emulsion with a partial cosmetic formulation that typically contains water, fragrance, a rheology modifier, or a pH adjuster, or a combination thereof. The present invention is also a composition comprising two particular subclasses of HIPR emollient-in-water emulsions, namely an HIPR silicone elastomer-in-water emulsion and an HIPR sunscreen-in-water emulsion. The use of an HIPR emulsion of a cosmetic emollient provides a simple and flexible method of formulating the cosmetic product, due in part to the long shelf-stability of the HIPR emulsion (>1 year), and the low quantity of water in the emulsion (typically less than 20% by volume based on the volume of emollient and water).

Abstract: The present invention provides a liquid deodorant suitable for deodorization of spaces and fiber products, and a hair cosmetic and skin cosmetic having a high deodorization effect. Here any of the hair cosmetic and skin cosmetic may be that referred to as a body deodorant. Namely, the present invention provides a deodorant comprising a deodorant organic dibasic acid composed of an organic dibasic acid and/or salt thereof having a difference between the first acid dissociation index (hereinafter, abbreviated as first acid dissociation index and the second acid dissociation index (hereinafter, abbreviated as second acid dissociation index or pK2) of 1.7 or more a 25° C.

Abstract: A drug delivery system is provided including a bulk polymer phase and a polymeric drug-enriched phase within the bulk polymer phase. At least one drug is incorporated into the drug-enriched phase. The system can be used, for example, on implantable medical devices such as stents.

Abstract: Disclosed herein is a stabilization method of nano-sized emulsion by using lecithin and tocopheryl derivatives represented by the following formula (I) and (Wherein, R1, R2 and R3 are H or methyl group, and at least one position selected from the group consisting of the R1, R2 and R3 positions are methyl group; and, A is CH2—CH(CH3)— or CH═C(CH3)—) and an external application for skin containing the stabilized nano-sized emulsion.

Abstract: Improvedly photostable, topically applicable cosmetic/dermatological sunscreen compositions well suited for enhanced photoprotection of human skin and/or hair against the damaging effects of UV-A and UV-B irradiation, particularly solar radiation, comprise (i) 4-tert-butyl-4′-methoxydibenzoylmethane, (ii) at least one particular 1,3,5-triazine compound, and (iii) at least one alkyl &agr;-cyano-&bgr;,&bgr;′-diphenylacrylate, formulated in a cosmetically/dermatologically acceptable vehicle, diluent or carrier therefor.

Abstract: A product for application to skin includes a container having an open end, a non-flowable composition within the container including an application surface at the open end having a visual pattern, and a removable cap having a % opacity of less than 5%.

Abstract: A method of preparing a sunscreen including a solvent system and a filter system, the method including the step of controlling the polarity of the solvent system to control the rate of photodecay of the filter system, as well as sunscreen compositions and compounds for producing sunscreen compositions, are disclosed. A method of selling a cosmetically-acceptable sunscreen composition is disclosed.

Abstract: A composition comprising an amphoteric or pseudo-amphoteric agent and a polyhydroxy alpha hydroxyacid existing as a free acid, lactone, or salt, and isomeric or non-isomeric forms thereof is provided. The amphoteric or pseudo-amphoteric agent can be selected from amino acids, dipeptides, aminoaldonic acid, aminouronic acid, lauryl aminoproplyglycine, aminoaldaric acid, neuraminic acid desulfated heparin, deacetylated hyaluronic acid, hyalobiuronic acid, chondrosine, deacetylated chondroitin, creatine, creatinine, hydroxyproline, homocysteine, homocystine, homoserine, ornithine, citrulline, phosphatidylserine, and sphingomyelin. The composition may contain other additives, including cosmetic or pharmaceutical agents for topical treatment of dermatological disorders.

Abstract: The present invention is a system for averting undesirable pharmacokinetic drug interaction between a drug and concomitant drug(s), which consists of controlling the in vivo release time and/or release site of the drug and/or the concomitant drug.